Defining early mycosis fungoides
Nicola Pimpinelli(University of Florence), Gary S. Wood(University of Wisconsin–Madison), Eric C. Vonderheid(Ashford and St Peter's Hospitals NHS Foundation Trust), Robert Knobler(Medical University of Vienna), Stuart R. Lessin(Fox Chase Cancer Center), Erik Obitz(Aarhus University), Werner Kempf(University Hospital of Zurich), Gladys H. Telang(Brown University), Keiji Iwatsuki(Okayama University), Elise A. Olsen(Durham Technical Community College), Earl J. Glusac(Yale University), Lorenzo Cerroni(Medical University of Graz), Joan Guitart(Northwestern Memorial Hospital), A Haeffner(University of Zurich), Peter Heald(Yale University), Sean Whittaker(Guy's Hospital), Christian A. Sander, Masahiro Takigawa(Hamamatsu University), Seth R. Stevens(The University of Texas at San Antonio Health Science Center), Guenter Burg(University of Zurich), Brigitte Dréno(Nantes Université), Maria L. Turner(National Institutes of Health), Marco Santucci(University of Florence)
Cited by 543
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma
|New England Journal of Medicine|2014|2k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
|Journal of Clinical Oncology|2000|1.3k